Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 29, 2005, 10.1148/radiol.2363040220
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2363040220v1
236/3/1041    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlosser, T.
Right arrow Articles by Barkhausen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlosser, T.
Right arrow Articles by Barkhausen, J.
(Radiology 2005;236:1041-1046.)
© RSNA, 2005


Technical Developments

Myocardial Infarct: Depiction with Contrast-enhanced MR Imaging—Comparison of Gadopentetate and Gadobenate1

Thomas Schlosser, MD, Peter Hunold, MD, Christoph U. Herborn, MD, Heidrun Lehmkuhl, MD, Alexander Lind, MD, Sandra Massing, RT and Jörg Barkhausen, MD

1 From the Departments of Diagnostic and Interventional Radiology (T.S., P.H., C.U.H., H.L., S.M., J.B.) and Cardiology (A.L.), University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany. Received February 5, 2004; revision requested April 13; final revision received October 3; accepted October 22. Address correspondence to J.B. (e-mail: joerg.barkhausen{at}uni-essen.de).

Institutional review board approval and patient written informed consent were obtained. On two separate occasions, 24 hours apart, contrast-enhanced cardiac magnetic resonance (MR) imaging was performed prospectively at 1, 3, 5, 10, and 20 minutes after injection of gadopentetate dimeglumine and gadobenate dimeglumine in 15 patients (11 men, four women) with history of myocardial infarction. Both agents allowed detection of infarcted myocardium. T1 values at all times were significantly (P < .05) lower for gadobenate, compared with values for gadopentetate, in both infarcted and noninfarcted myocardium. At 1 minute after administration of both agents, T1 values in left ventricular cavity (LVC) were not different; at 3–20 minutes after injection, values were significantly (P < .05) lower for gadobenate. Differences between contrast-to-noise ratio (CNR) values of infarcted and noninfarcted myocardium were significantly higher on gadobenate-enhanced images (P < .05). CNR values between infarcted myocardium and LVC were significantly higher on gadopentetate-enhanced images (P < .05). Gadopentetate might permit better delineation of infarcts, especially subendocardial infarcts.

© RSNA, 2005




This article has been cited by other articles:


Home page
RadiologyHome page
F. Sardanelli, M. Quarenghi, T. Schlosser, and J. Barkhausen
Delayed Enhancement of Subendocardial Infarcted Myocardium with Gadobenate Dimeglumine: A Paradoxical Effect--Is a Double Dose Too Much?
Radiology, September 1, 2006; 240(3): 914 - 916.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2005 by the Radiological Society of North America.